Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danavorexton in Anesthetized Adults
NCT05025397Phase 1Completed
- Sponsor
- Takeda
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of danavorexton in delayed emergence from anesthesia (4 cohorts), sponsored by Takeda. Primary endpoint: Number of Participants With at Least one Treatment-emergent Adverse Event. Started Sep 2021; status: completed.
02
Drugs
danavorexton
03
Conditions
delayed emergence from anesthesia
Beyond the preview
Go deeper on NCT05025397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05025397.